Next Article in Journal
Special Issue “Molecular Insights into the Role of Exercise in Disease and Health”
Previous Article in Journal
Interleukin-6, Tocilizumab and Atherosclerosis. Comment on Gerasimova et al. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2024, 25, 12425
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Reply

Reply to Saleh, C.; Budincevic, H. Interleukin-6, Tocilizumab and Atherosclerosis. Comment on “Gerasimova et al. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2024, 25, 12425”

by
Elena Gerasimova
1,*,
Tatiana V. Popkova
1,
Irina G. Kirillova
1,
Daria Gerasimova
2,
Evgenii L. Nasonov
1,2 and
Aleksandr M. Lila
1,3
1
Department of Systemic Rheumatic Diseases, V.A. Nasonova Research Institute of Rheumatology, Kashirskoe Shosse, 115522 Moscow, Russia
2
Chair of Organization and Economy of Pharmacy, Institute of Pharmacy, A.P. Nelyubina, I.M. Sechenov First Moscow State Medical University (Sechenov University), 96k1 Ave. Vernadsky, 119526 Moscow, Russia
3
Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation, Build 1, 2/1 Barrikadnaya St., 125993 Moscow, Russia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(7), 2953; https://doi.org/10.3390/ijms26072953
Submission received: 17 February 2025 / Revised: 10 March 2025 / Accepted: 14 March 2025 / Published: 25 March 2025
(This article belongs to the Section Molecular Immunology)

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

We thank the authors for their interest in our study [...]

Share and Cite

MDPI and ACS Style

Gerasimova, E.; Popkova, T.V.; Kirillova, I.G.; Gerasimova, D.; Nasonov, E.L.; Lila, A.M. Reply to Saleh, C.; Budincevic, H. Interleukin-6, Tocilizumab and Atherosclerosis. Comment on “Gerasimova et al. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2024, 25, 12425”. Int. J. Mol. Sci. 2025, 26, 2953. https://doi.org/10.3390/ijms26072953

AMA Style

Gerasimova E, Popkova TV, Kirillova IG, Gerasimova D, Nasonov EL, Lila AM. Reply to Saleh, C.; Budincevic, H. Interleukin-6, Tocilizumab and Atherosclerosis. Comment on “Gerasimova et al. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2024, 25, 12425”. International Journal of Molecular Sciences. 2025; 26(7):2953. https://doi.org/10.3390/ijms26072953

Chicago/Turabian Style

Gerasimova, Elena, Tatiana V. Popkova, Irina G. Kirillova, Daria Gerasimova, Evgenii L. Nasonov, and Aleksandr M. Lila. 2025. "Reply to Saleh, C.; Budincevic, H. Interleukin-6, Tocilizumab and Atherosclerosis. Comment on “Gerasimova et al. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2024, 25, 12425”" International Journal of Molecular Sciences 26, no. 7: 2953. https://doi.org/10.3390/ijms26072953

APA Style

Gerasimova, E., Popkova, T. V., Kirillova, I. G., Gerasimova, D., Nasonov, E. L., & Lila, A. M. (2025). Reply to Saleh, C.; Budincevic, H. Interleukin-6, Tocilizumab and Atherosclerosis. Comment on “Gerasimova et al. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2024, 25, 12425”. International Journal of Molecular Sciences, 26(7), 2953. https://doi.org/10.3390/ijms26072953

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop